Literature DB >> 22334345

The use of raw scores from ordinal scales: time to end malpractice?

Gunnar Grimby, Alan Tennant, Luigi Tesio.   

Abstract

Mesh：

Year:  2012        PMID： 22334345     DOI： 10.2340/16501977-0938

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN： 1650-1977            Impact factor:   2.912


× No keyword cloud information.
  37 in total

Review 1.  Prognostic factors for the course of functional status of patients with ALS: a systematic review.

Authors:  Huub Creemers; Hepke Grupstra; Frans Nollet; Leonard H van den Berg; Anita Beelen
Journal:  J Neurol       Date:  2014-11-11       Impact factor: 4.849

2.  A Rasch-validated version of the upper extremity functional index for interval-level measurement of upper extremity function.

Authors:  Clayon B Hamilton; Bert M Chesworth
Journal:  Phys Ther       Date:  2013-06-27

Review 3.  Optimizing Outcome Assessment in Multicenter TBI Trials: Perspectives From TRACK-TBI and the TBI Endpoints Development Initiative.

Authors:  Yelena G Bodien; Michael McCrea; Sureyya Dikmen; Nancy Temkin; Kim Boase; Joan Machamer; Sabrina R Taylor; Mark Sherer; Harvey Levin; Joel H Kramer; John D Corrigan; Thomas W McAllister; John Whyte; Geoffrey T Manley; Joseph T Giacino
Journal:  J Head Trauma Rehabil       Date:  2018 May/Jun       Impact factor: 2.710

4.  Joint modeling of multiple repeated measures and survival data using multidimensional latent trait linear mixed model.

Authors:  Jue Wang; Sheng Luo
Journal:  Stat Methods Med Res       Date:  2018-10-11       Impact factor: 3.021

5.  Walking speed best explains perceived locomotion ability in ambulatory people with chronic stroke, assessed by the ABILOCO questionnaire.

Authors:  Patrick R Avelino; Kênia K P Menezes; Lucas Rodrigues Nascimento; Iza Faria-Fortini; Christina Danielle Coelho de Morais Faria; Luci F Teixeira-Salmela
Journal:  Braz J Phys Ther       Date:  2018-12-24       Impact factor: 3.377

6.  Reliability and Validity of the Turkish Version of the ABILHAND Questionnaire in Rheumatoid Arthritis Individuals, Based on Rasch Analysis.

Authors:  Bilge Başakci Çalik; Elif Gür Kabul; Murat Taşçi; Suat Erel; İbrahim Engin Şimşek; Pervin Demir; Veli Çobankara
Journal:  Arch Rheumatol       Date:  2019-04-26       Impact factor: 1.472

7.  Value Assessment, Real World Evidence and Fundamental Measurement: Version 3.0 of the Minnesota Formulary Submission Guidelines.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2020-11-12

8.  To Dream the Impossible Dream: The Commitment by the Institute for Clinical and Economic Review to Rewrite the Axioms of Fundamental Measurement for Hemophilia A and Bladder Cancer Value Claims.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2020-12-10

9.  Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2021-02-16

10.  The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).

Authors:  Karlien Mul; Tatiana Hamadeh; Corinne G C Horlings; Rabi Tawil; Jeffrey M Statland; Sabrina Sacconi; Alastair J Corbett; Nicol C Voermans; Catharina G Faber; Baziel G M van Engelen; Ingemar S J Merkies
Journal:  Eur J Neurol       Date:  2021-05-02       Impact factor: 6.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.